Business Context and Reporting Period
Company: Kewaunee Scientific Corporation (KEQU)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended October 31, 2024
Business Overview: The Company designs, manufactures, and installs scientific and technical furniture, including laboratory cabinetry and fume hoods. Operations are segmented into Domestic and International divisions.
Key Financial Metrics
| Metric ($ in thousands) | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Net Sales | $47,764 | $50,436 | $96,157 | $100,275 |
| Gross Profit | $13,952 | $13,468 | $26,440 | $25,382 |
| Gross Margin % | 29.2% | 26.7% | 27.5% | 25.3% |
| Operating Profit | $4,434 | $5,109 | $7,009 | $8,917 |
| Net Earnings (Attributable to Kewaunee) | $3,008 | $2,732 | $5,201 | $5,206 |
| Diluted EPS | $1.01 | $0.93 | $1.75 | $1.79 |
| Cash from Operations (YTD) | $7,642 (2024) vs $8,919 (2023) | |||
| Order Backlog | $184.4 million (as of Oct 31, 2024) | |||
| Working Capital | $59,965 (as of Oct 31, 2024) |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 5.3% in Q2 and 4.1% YTD compared to the prior year. This was driven by a 30.1% drop in International sales due to construction delays in India, partially offset by a 6.5% increase in Domestic sales.
- Margin Expansion: Gross profit margins improved significantly (29.2% in Q2 vs. 26.7% prior year) due to enhanced manufacturing productivity and cost-containment measures.
- Operating Expenses: Operating expenses increased 13.9% in Q2 and 18.0% YTD. Increases were primarily due to one-time consulting fees related to the Nu Aire acquisition and Sarbanes-Oxley 404(b) compliance readiness.
- Tax Rate Improvement: The effective tax rate decreased to 23.3% in Q2 (from 41.6% prior year) and 17.4% YTD (from 35.3% prior year), aided by a discrete tax benefit of $421,000 from stock issuances.
- Debt Restructuring: The Company terminated its previous Revolving Credit Facility on September 30, 2024, paying off a $3.0 million balance and incurring $0.5 million in termination expenses.
Guidance, Outlook, and Risks
Acquisition of Nu Aire, Inc.
On November 1, 2024, the Company completed the acquisition of Nu Aire, Inc. for $55.0 million. The purchase price was funded via $32.0 million in cash (partially from new debt) and $23.0 million in subordinated Seller Notes. Nu Aire specializes in biological safety cabinets and airflow products, expanding Kewaunee's product portfolio and distribution channels.
Financing
Concurrent with the acquisition, the Company entered a new Loan Agreement with PNC Bank, National Association, comprising a $20.0 million Revolving Credit Facility and a $15.0 million Term Loan, maturing in 2029.
Risks and Contingencies
- Integration Risk: The Company faces risks in integrating Nu Aire, including potential difficulties in aligning internal controls, as Nu Aire was not previously subject to Sarbanes-Oxley requirements.
- Market Dependence: Demand remains dependent on laboratory construction projects and raw material costs (steel, wood, epoxy resin).
- International Exposure: Continued volatility in international markets, specifically India, impacts revenue timing.
Investor Verification Checklist
- Acquisition Integration: Monitor the successful integration of Nu Aire's operations and internal controls to ensure compliance with Section 404 of Sarbanes-Oxley.
- Debt Covenants: Verify compliance with the new PNC Loan Agreement covenants, specifically the senior funded indebtedness to EBITDA ratio (max 2.50:1) and fixed charge coverage ratio (min 1.20:1).
- International Recovery: Track the resolution of construction delays in India to assess the recovery of International segment revenue.
- Margin Sustainability: Confirm if the improved gross margins (29.2%) are sustainable amidst potential raw material cost fluctuations.
- Backlog Conversion: Assess the conversion rate of the $184.4 million order backlog into recognized revenue in upcoming quarters.